Vycor Medical, Inc.
VYCO
$0.1179
$0.011310.60%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.60K | -6.70K | -59.80K | -10.00K | -30.60K |
| Total Depreciation and Amortization | 16.10K | 16.90K | 15.70K | 15.70K | 15.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 18.40K | 18.40K | 4.70K | 0.00 | 7.30K |
| Change in Net Operating Assets | -22.80K | -66.80K | 49.90K | 80.30K | 9.50K |
| Cash from Operations | -26.90K | -38.30K | 10.50K | 86.00K | 1.90K |
| Capital Expenditure | -- | 200.00 | -4.40K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -700.00 | 0.00 | 700.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 200.00 | -5.00K | 0.00 | 700.00 |
| Total Debt Issued | -- | 0.00 | 61.00K | -- | -- |
| Total Debt Repaid | -17.70K | -13.90K | -28.10K | -10.60K | -16.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -17.70K | -13.90K | 32.90K | -10.60K | -16.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -44.60K | -52.00K | 38.30K | 75.40K | -13.40K |